Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: J Card Fail. 2014 May 28;20(8):593–601. doi: 10.1016/j.cardfail.2014.05.006

Figure 1.

Figure 1

In-hospital inotrope use and risk for death, ventricular assist device implantation, or heart transplantation by 180 days according to baseline cardiac index (N=196). The hazard ratio represents the effect of in-hospital inotrope use compared with no inotrope use as reference. There was a trend towards higher risk for major clinical events with use of inotropes with increasing cardiac index. The interaction term, however, was not statistically significant (P=0.092) in a model adjusting for age, sex, body mass index, left ventricular ejection fraction, admission systolic blood pressure, blood urea nitrogen, sodium, and hemoglobin.